The Concept of CMREvaluating CMRManaging CMRDocumentation Center
Print this pageDecrease text sizeIncrease text size

Managing Cardiometabolic Risk

Targeting Traditional CVD Risk Factors in Patients with Abdominal Obesity

Numerous organizations have published an array of guidelines on managing acknowledged risk factors for cardiovascular disease. Among the management approaches used are treatment of hypertension and dyslipidemia (lowering LDL cholesterol in particular), smoking cessation, and better glycemic control. These measures can produce significant clinical benefits for the patient. This section provides useful links and information to help you better manage these risk factors.

Document Center

A Simplified View of Victor Dzau´s Cardiovascular Continuum by Luis Miguel Ruilope, MD

A Simplified View of Victor Dzau´s Cardiovascular Continuum by Luis Miguel Ruilope, MD

More
Which factors/markers do you think will emerge as key predictors of global CMR beyond the Framingham risk score?

Which factors/markers do you think will emerge as key predictors of global CMR beyond the Framingham risk score?

More
Post-AHA 2007: Lifestyle intervention

Post-AHA 2007: Lifestyle intervention

More
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2008;197:355-62

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2008;197:355-62

More
Evidence for a greater relative accumulation of intra-abdominal adipose tissue (AT) in Japanese than Caucasian Americans

Evidence for a greater relative accumulation of intra-abdominal adipose tissue (AT) in Japanese than Caucasian Americans

More